Improved Cardiac Performance with Dexamethasone Therapy in Premature Neonates: Novel Insights Using Serial Echocardiographic Assessments
(1) Background: dexamethasone is used for the prevention and treatment of chronic lung disease (CLD) in premature neonates, and its impact on cardiac performance and pulmonary vascular resistance has not been well studied. (2) Methods: eligible neonates of <30 weeks gestational age (GA) had echoc...
Main Authors: | Jejelola Ladele, Ayman Saker, Talal Altamimi, Andrea De La Hoz, Renjini Lalitha, Michael R. Miller, Soume Bhattacharya |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/13/20/11380 |
Similar Items
-
Effectiveness of antenatal dexamethasone in reducing respiratory distress syndrome and mortality in preterm neonates: a nested case control study
by: Wema Kibanga, et al.
Published: (2023-03-01) -
Obstacles to the Early Diagnosis and Management of Patent Ductus Arteriosus
by: Gowda SH, et al.
Published: (2024-02-01) -
Effects of antenatal corticosteroids on neonatal blood glucose fluctuation in late-preterm infants
by: Cailing Zhou, et al.
Published: (2022-11-01) -
Mucormycosis of the colon in a premature neonate
by: Pradeep Kajal, et al.
Published: (2022-07-01) -
A case-control study on the effects of incomplete, one, and more than one dexamethasone course on acute respiratory problems in preterm neonates born between 280 and 366 weeks of gestation
by: Saifon Chawanpaiboon, et al.
Published: (2022-11-01)